Drugs indexed in China
37 drugs indexed · 5 prices independently verified. Each entry shows China approval status and price only where a source supports it.
AbemaciclibCDK4/6
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Alectinib2nd-generation ALK-TKI
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- https://www.himd.com/alectinib/22237283
Secondary source (media / community / commercial)
Last checked2026-09-08
Almonertinib3rd-generation EGFR-TKI
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Anlotinib(TKI, )
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
AtezolizumabPD-L1 inhibitor
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Axicabtagene ciloleucel (CAR-T)CD19 CAR-T cell therapy
What this meansChecked against a primary or official source.
Source(s)
- 163.com/dy/article/JE0BDJK60552IJOG.html
Secondary source (media / community / commercial) - xueqiu.com/4097176039/338291915
Secondary source (media / community / commercial)
Last checked2026-09-08
BevacizumabVEGF
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
CamrelizumabPD-1 inhibitor
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
DalpiciclibCDK4/6
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Disitamab vedotin (RC48)(ADC, HER2)
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
DurvalumabPD-L1 inhibitor
What this meansChecked against a primary or official source.
Source(s)
- https://www.himd.com/nivolumab/232263
Secondary source (media / community / commercial)
Last checked2026-09-08
Ensartinib2nd-generation ALK-TKI
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Equecabtagene AutoleucelBCMA CAR-T cell therapy
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
FluzoparibPARP
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Furmonertinib3rd-generation EGFR-TKI
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
IbrutinibBTK
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Lecheng Special Access Channel (485+ pre-NMPA drugs & devices)Policy channel (not a single drug)
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
Lenvatinib- en.hainan.gov.cn 2026-06 (485+ 目录规模)
Official / government source
(TKI, )
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Lorlatinib3rd-generation ALK-TKI
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- https://www.himd.com/lorlatinib/22237888
Secondary source (media / community / commercial)
Last checked2026-09-08
NiraparibPARP
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
NivolumabPD-1 inhibitor
What this meansChecked against a primary or official source.
Source(s)
- https://www.aihope.cn/article/detail/6842
Secondary source (media / community / commercial)
Last checked2026-09-08
OlaparibPARP
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Osimertinib3rd-gen EGFR TKI
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
PalbociclibCDK4/6
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
PembrolizumabPD-1 inhibitor
What this meansChecked against a primary or official source.
Source(s)
- health.baidu.com/m/detail/ar_6101301212440287301
Secondary source (media / community / commercial) - aihope.cn/article/detail/7077
Secondary source (media / community / commercial)
Last checked2026-09-08
PertuzumabHER2(,)
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
PyrotinibHER(TKI, )
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Regorafenib(TKI, )
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Relmacabtagene autoleucel (CAR-T)CD19 CAR-T cell therapy
What this meansChecked against a primary or official source.
Source(s)
- 163.com/dy/article/JE0BDJK60552IJOG.html
Secondary source (media / community / commercial) - xueqiu.com/4097176039/338291915
Secondary source (media / community / commercial)
Last checked2026-09-08
Sacituzumab govitecan(ADC, Trop-2)
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
SintilimabPD-1 inhibitor
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- https://www.nhsa.gov.cn/attach/Ypsn2025/YPSN202500227/YPSN202500227.pdf
Official / government source
Last checked2026-09-08
TislelizumabPD-1 inhibitor
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
ToripalimabPD-1 inhibitor
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
Source(s)
- https://www.himd.com/toripalimab/22236839
Secondary source (media / community / commercial)
Last checked2026-09-08
TrastuzumabHER2
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
Trastuzumab deruxtecan (T-DXd)HER2 ADC
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
VenetoclaxBCL-2
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08
ZanubrutinibBTK
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
Last checked2026-09-08